Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
SmartFinancial
SMBK
$900M
| $937K | ﹤0.01% |
36,225
+1,384
| +4% | +$34.2K |
|
|
ZIXI
2902
DELISTED
Zix Corporation
ZIXI
| $936K | ﹤0.01% |
132,281
-639
| -0.5% | -$4.61K |
|
|
NEUE
2903
DELISTED
NeueHealth
NEUE
| $923K | ﹤0.01% |
+1,413
| New | +$1.24M |
|
2904
EverQuote
EVER
$874M
| $920K | ﹤0.01% |
49,377
-42,914
| -46% | -$1.03M |
|
2905
Daily Journal
DJCO
$804M
| $913K | ﹤0.01% |
2,848
-6
| -0.2% | -$1.97K |
|
2906
RBB Bancorp
RBB
$462M
| $911K | ﹤0.01% |
36,132
+1,934
| +6% | +$47.4K |
|
|
KALV
2907
DELISTED
KalVista Pharmaceuticals
KALV
| $910K | ﹤0.01% |
52,098
+3,937
| +8% | +$79.8K |
|
2908
Old Second Bancorp
OSBC
$1.31B
| $909K | ﹤0.01% |
69,591
-24,730
| -26% | -$297K |
|
2909
SIGA Technologies
SIGA
$208M
| $906K | ﹤0.01% |
122,529
-189,130
| -61% | -$1.21M |
|
2910
Century Casinos
CNTY
$35.2M
| $903K | ﹤0.01% |
67,003
+157
| +0.2% | +$2K |
|
2911
American Outdoor Brands
AOUT
$162M
| $901K | ﹤0.01% |
36,669
-60,125
| -62% | -$1.69M |
|
|
XIFR
2912
XPLR Infrastructure LP
XIFR
$1.1B
| $901K | ﹤0.01% |
11,957
-201
| -2% | -$15.7K |
|
2913
Rekor Systems
REKR
$98.2M
| $900K | ﹤0.01% |
78,321
+46
| +0.1% | +$418 |
|
2914
Arbutus Biopharma
ABUS
$898M
| $899K | ﹤0.01% |
209,375
+22,907
| +12% | +$76.3K |
|
2915
Full House Resorts
FLL
$85.4M
| $899K | ﹤0.01% |
84,652
+5,928
| +8% | +$50.6K |
|
2916
W&T Offshore
WTI
$543M
| $896K | ﹤0.01% |
240,740
-405,392
| -63% | -$1.45M |
|
|
SPPI
2917
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $893K | ﹤0.01% |
409,725
-685,864
| -63% | -$1.87M |
|
|
PRVB
2918
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $886K | ﹤0.01% |
138,358
-236,596
| -63% | -$1.52M |
|
|
EBTC
2919
DELISTED
Enterprise Bancorp
EBTC
| $873K | ﹤0.01% |
24,275
+1,587
| +7% | +$53.1K |
|
2920
Southern Missouri Bancorp
SMBC
$849M
| $872K | ﹤0.01% |
19,423
-25
| -0.1% | -$1.12K |
|
|
CAMP
2921
DELISTED
CalAmp Corp.
CAMP
| $872K | ﹤0.01% |
3,808
-6,852
| -64% | -$1.81M |
|
2922
Civista Bancshares
CIVB
$595M
| $867K | ﹤0.01% |
37,314
-10,563
| -22% | -$243K |
|
2923
Sierra Bancorp
BSRR
$531M
| $865K | ﹤0.01% |
35,614
-53
| -0.1% | -$1.29K |
|
|
FPI
2924
Farmland Partners
FPI
$426M
| $864K | ﹤0.01% |
72,049
+5,120
| +8% | +$63.2K |
|
2925
Q32 Bio
QTTB
$468M
| $861K | ﹤0.01% |
6,077
-10,720
| -64% | -$1.37M |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.